Bay Street News, 2018

BRIDGEWATER, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) — Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of […]

BOSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc., (Nasdaq:ZIOP) today announced a clinical supply agreement with Regeneron Pharmaceuticals, […]

Updates Fiscal Year 2018 Guidance IRVING, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) — Del Frisco’s Restaurant Group, Inc. (“Del Frisco’s”) […]

– Checkpoint combination studies support progression into registration pathway for metastatic breast cancer and potential expansion of indications – – […]

YONKERS, N.Y., Nov. 12, 2018 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]

Focus will be on Milestones for Development and Commercialization CAP-1002 Therapy for Duchenne Muscular Dystrophy LOS ANGELES, Nov. 12, 2018 […]

HOUSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) — DynaEnergetics, a business of DMC Global Inc. (Nasdaq: BOOM), today announced it has […]

Summit Therapeutics plc  (‘Summit’ or the ’Company’) Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness […]

CRANBURY, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and […]

Mersana Chief Scientific Officer, Timothy B. Lowinger, Ph.D. to chair 2018 Conference CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) — […]